CLSDX
Price
$33.54
Change
+$0.01 (+0.03%)
Updated
Aug 10 closing price
Net Assets
2.3B
VMGMX
Price
$131.43
Change
-$0.39 (-0.30%)
Updated
Aug 10 closing price
Net Assets
33.5B
Interact to see
Advertisement

CLSDX vs VMGMX

CLSDX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.5B vs. CLSDX (2.3B). VMGMX pays higher dividends than CLSDX: VMGMX (0.61) vs CLSDX (0.00). CLSDX was incepted earlier than VMGMX: CLSDX (2 years) vs VMGMX (15 years). CLSDX (0.88) is less costly to investors than VMGMX (0.07). CLSDX is a more actively managed with annual turnover of: 200.00 vs. VMGMX (17.00). CLSDX has a lower initial minimum investment than VMGMX: CLSDX (0) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 7.68 vs. CLSDX (6.61).
CLSDXVMGMXCLSDX / VMGMX
Total Expense Ratio0.870.071,243%
Annual Report Gross Expense Ratio0.880.071,257%
Fund Existence2 years15 years-
Gain YTD18.6489.762191%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B33.5B7%
Annual Yield % from dividends0.000.61-
Returns for 1 year6.617.6886%
Returns for 3 yearsN/A51.17-
Returns for 5 yearsN/A27.13-
Returns for 10 yearsN/A190.62-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KIQQ25.130.19
+0.75%
KraneSharesInspereXNasdaqDynBfrdHInIdETF
PJP125.450.60
+0.48%
Invesco Pharmaceuticals ETF
CPRY28.16-0.01
-0.05%
Calamos Russell 2000 Str Alt Prt ETF-Jan
IBDV21.58-0.06
-0.25%
iShares iBonds Dec 2030 Term Corp ETF
IZRL29.77-0.19
-0.63%
ARK Israel Innovative Technology ETF